Dyslipidaemia in nephrotic syndrome: mechanisms and treatment

S Agrawal, JJ Zaritsky, A Fornoni… - Nature Reviews …, 2018 - nature.com
Nephrotic syndrome is a highly prevalent disease that is associated with high morbidity
despite notable advances in its treatment. Many of the complications of nephrotic syndrome …

Nephrotic syndrome in childhood

AA Eddy, JM Symons - The lancet, 2003 - thelancet.com
Childhood nephrotic syndromes are most commonly caused by one of two idiopathic
diseases: minimal-change nephrotic syndrome (MCNS) and focal segmental …

Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities

L Opazo-Ríos, S Mas, G Marín-Royo… - International journal of …, 2020 - mdpi.com
Lipotoxicity is characterized by the ectopic accumulation of lipids in organs different from
adipose tissue. Lipotoxicity is mainly associated with dysfunctional signaling and insulin …

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis

SC Palmer, JC Craig, SD Navaneethan… - Annals of internal …, 2012 - acpjournals.org
Background: Statins have uncertain benefits in persons with chronic kidney disease (CKD)
because individual trials may have insufficient power to determine whether treatment effects …

Effect of statins on kidney disease outcomes: a systematic review and meta-analysis

X Su, L Zhang, J Lv, J Wang, W Hou, X Xie… - American Journal of …, 2016 - Elsevier
Background The effects of statin administration on kidney disease outcomes remain
controversial. We undertook a systematic review and meta-analysis to assess the efficacy of …

Evidence-based clinical practice guidelines for nephrotic syndrome 2014

S Nishi, Y Ubara, Y Utsunomiya, K Okada… - Clinical and …, 2016 - Springer
In Japan, original researches on nephrotic syndrome (NS) were initially performed by the
Ministry of Health, Labour and Welfare (MHLW) NS research group. The first definition of NS …

Management of glomerular proteinuria: a commentary

WA Wilmer, BH Rovin, CJ Hebert, SV Rao… - Journal of the …, 2003 - journals.lww.com
It is widely accepted that proteinuria reduction is an appropriate therapeutic goal in chronic
proteinuric kidney disease. Based on large randomized controlled clinical trials (RCT), ACE …

Secondary dyslipidemia: its treatments and association with atherosclerosis

H Yanai, H Yoshida - Global health & medicine, 2021 - jstage.jst.go.jp
Dyslipidemia is classified into primary and secondary types. Primary dyslipidemia is
basically inherited and caused by single or multiple gene mutations that result in either …

Effects of statins on renal function

R Agarwal - Mayo Clinic Proceedings, 2007 - Elsevier
Patients with chronic kidney disease (CKD) are much more likely to die of cardiovascular
disease than end-stage renal disease. Dyslipidemia is highly prevalent in patients with CKD …

Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis

K Esmeijer, OM Dekkers, JW de Fijter, FW Dekker… - Scientific reports, 2019 - nature.com
Previous studies showed that statins reduce the progression of kidney function decline and
proteinuria, but whether specific types of statins are more beneficial than others remains …